Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

212 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Completed

FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status

NCT03142516

Conditions
Colonic Diseases, Colorectal Cancer Metastatic, Colorectal Carcinoma, +14 more
Locations
  • ICO L´Hospitalet de Llobregat - Hospital Durán i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Sant Joan Despí-Moises Broggi Sant Joan Despí, Barcelona, Spain
  • Hospital Universitario Puerta de Hierro-Majadahonda Majadahonda, Madrid, Spain
  • Hospital Universitario Rey Juan Carlos Móstoles, Madrid, Spain
View Trial Details
Completed

A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone

NCT00545129

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations
  • UCSD Center for Pain Medicine La Jolla, California, United States
  • UCSD Medical Center - Thornton Hospital La Jolla, California, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Indiana Pain and Spine Clinic South Bend, Indiana, United States
View all 39 locations
View Trial Details
Completed

TheraSphere for the Treatment of Liver Metastases

NCT00511862

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +22 more
Locations
  • Northwestern Memorial Hospital, Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • John Hopkins Hospital Baltimore, Maryland, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Albany Medical Center Albany, New York, United States
View Trial Details
Completed

A Study of LY2835219 in Japanese Participants With Advanced Cancer

NCT02014129

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Tokyo, Japan
View Trial Details
Completed

A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)

NCT02411591

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Charleroi, Belgium
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Leuven, Belgium
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Roeselare, Belgium
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Brest, France
View all 15 locations
View Trial Details

Related conditions